Semaglutide vs Tirzepatide vs Retatrutide for Men

Men's weight loss on GLP-1 medications involves unique considerations: testosterone levels, visceral fat distribution, muscle mass preservation, and cardiovascular risk that differs from women. Here is how semaglutide, tirzepatide, and retatrutide compare for men's specific health goals.

Head-to-Head Comparison for Men

Men-Specific Considerations

Testosterone and Visceral Fat

Men carry more visceral fat (around organs) than women, and visceral fat is the primary site of aromatase activity, the enzyme that converts testosterone to estrogen. Losing visceral fat directly improves testosterone levels. Studies show that 10-15% weight loss can increase total testosterone by 100-200 ng/dL.

Retatrutide may have an advantage here because the glucagon receptor component specifically targets visceral and hepatic fat, potentially producing the greatest testosterone recovery per unit of weight lost.

Muscle Preservation

Men typically start with more muscle mass and have more to lose. Up to 40% of weight lost on GLP-1 can be lean mass without intervention. Men who prioritize resistance training and high protein intake (1.2-1.6g/kg daily) can reduce lean mass loss to 15-20% of total weight lost.

Semaglutide's slower weight loss rate may offer a slight advantage for muscle preservation simply because the body has more time to adapt. However, with proper exercise and nutrition, all three medications can produce excellent body composition outcomes.

Cardiovascular Risk

Men have higher baseline cardiovascular risk than women at every age. Semaglutide has the strongest cardiovascular evidence (SELECT trial, 20% MACE reduction). For men with established heart disease or high cardiovascular risk, semaglutide is the strongest evidence-based choice.

Sleep Apnea

Men are 2-3 times more likely than women to have obstructive sleep apnea. All GLP-1 medications improve sleep apnea through weight loss, but tirzepatide has specific FDA approval for moderate-to-severe OSA in obese patients (SURMOUNT-OSA trial).

Sexual Function

Improved testosterone, reduced inflammation, better cardiovascular function, and improved self-confidence all contribute to better sexual function. These benefits are proportional to weight loss and metabolic improvement, meaning the more effective the medication, the greater the potential improvement.

Recommendations by Health Profile

• High cardiovascular risk: Semaglutide (strongest heart data)
• Maximum weight loss priority: Retatrutide or tirzepatide
• Muscle preservation priority: Semaglutide (slower, steadier loss) with aggressive resistance training
• Sleep apnea: Tirzepatide (FDA-approved for OSA)
• Low testosterone: Any GLP-1 with focus on visceral fat reduction; retatrutide may have an edge
• Budget conscious: Semaglutide at $125/month from Trimi

Find Your Best Option with Trimi

Trimi helps men choose the right GLP-1 for their goals. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month. Visit our treatment page to start.

Frequently Asked Questions

Do men lose weight faster than women on GLP-1?

Men tend to lose weight slightly faster initially due to higher baseline metabolic rate and more visceral fat (which is mobilized more quickly than subcutaneous fat). However, the total percentage of body weight lost at 12 months is similar between men and women in clinical trials.

Will GLP-1 affect my strength training?

Reduced caloric intake can affect workout performance, particularly during heavy lifting. Ensure adequate protein and carbohydrate intake around workouts. Some men reduce training volume slightly during dose titration but maintain or increase it once stabilized on their dose.

Should I take testosterone replacement alongside GLP-1?

If you have diagnosed hypogonadism, discuss with your endocrinologist. Many men on GLP-1 see sufficient testosterone improvement from weight loss alone to avoid or reduce TRT. Have your testosterone levels checked before and during treatment to guide this decision.